Dpbioinnovations
1 known investors
DP BioInnovations develops an implantable, bioresorbable medical device designed to regenerate damaged esophageal tissue in patients with severe GERD, advanced Barrett's Esophagus, esophageal cancer, and pediatric birth defects. The device aims to replace surgical reconstruction and addresses a $20 billion U.S. market opportunity.
BiotechDeep TechMedical Devices